Notes on Blarcamesine and APOE4 and EMA impact

Blarcamesine vs Donepezil -- long term comparison

Aducanumab, Blarcamesine, Donanemab and Lecanemab Compared!

Annovis and Anavex A2-73 Parkinson Data Comparison

Screening / Diagnostic Testing and the Receiver Operating Characteristics (ROC) Curve

Free Simple Normal Distribution Plotter

The Endocrine Hypothalamus Cascade diagram on one sheet

Tomato Data

Sullivan Cave Sump Trip 1985

Sullivan Cave Trip 1985-1

Sullivan Cave Trip 1986-1

Sullivan Cave Trip 1986-2

Sullivan Cave Trip July1986

Salamander Cave Circa 1985

U.S. Naval Training Station, Great Lakes, Illinois - 1943

Fort Gordon Basic Training 1962-1963

Mao A-Min Song Translations

Welcome!

This site serves to publish MAXimum HIGH TECH information, historical information, and information that is, for the most part, not available at any other website.

***LATEST ARTICLE***
Notes On APOE4 and Potential EMA Blarcamesine Approval
Some comments regarding patient APOE4 status and recent Anavex pre-publications, and their possible affect on EMA resubmission. ---Max


Be sure to check out similar articles by Piotr Pietrzkiewicz at his Bio_oko patreon blog. ---Max


Other Articles

Additionally, we have an article comparing the ADAS-Cog results of the four Alzheimer's drugs - Aducanumab, Blarcamesine, Donanemab and Lecanemab!

For Parkinson's Disease, an efficacy comparison of Annovis's drug and the Anavex drug.